Wed, Apr 30, 3:52 PM (12 days ago)
**Nutex Health Inc. (NUTX) Form 10-K/A Amendment Summary** **Company Overview:** Nutex Health Inc. (NUTX) filed this Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The amendment includes information required by Items 10 through 14 of Part III of Form 10-K, which were previously omitted from the Original Filing. **Directors and Executive Officers:** - **Thomas T. Vo, M.D., MBA:** CEO and Chairman of the Board. - **Warren Hosseinion, M.D.:** President and Director. - **Jon C. Bates, MBA, CPA:** Chief Financial Officer. - **Michael Chang, M.D.:** Chief Medical Officer. - **Elisa Luqman, ESQ., MBA:** Chief Legal Officer (SEC). - **Pamela Montgomery, R.N., J.D.:** Chief Legal Officer (Healthcare & Secretary). - **Mitchell Creem, MHA:** Independent Director. - **Cheryl Grenas, R.N., M.S.N.:** Independent Director. - **Michael L. Reed, MPH:** Independent Director. - **Scott J. Saunders, MPPM:** Independent Director. - **Kelvin Spears, M.D.:** Director. **Executive Compensation:** - **Thomas T. Vo:** Base salary reduced to $500,000 in 2024, restored to $1,000,000 in 2025. - **Warren Hosseinion:** Base salary of $750,000. - **Jon C. Bates:** Base salary increased to $350,000 in 2024. - **Joshua DeTillio:** Base salary of $425,000. **Board Structure and Committees:** - **Audit Committee:** Mitchell Creem (Chair), Michael Reed, Scott J. Saunders. - **Compensation Committee:** Cheryl Grenas (Chair), Mitchell Creem, Michael Reed. - **Nominating and Governance Committee:** Michael Reed (Chair), Mitchell Creem, Scott J. Saunders, Cheryl Grenas. **Risk Oversight:** - The Board oversees risk management processes, including financial risks, cybersecurity, and compliance. **Related Person Transactions:** - Transactions with related parties, including leases and managerial services, were conducted on arm's-length terms. **Principal Accountant Fees:** - **Audit Fees:** $1,507,567 in 2024. - **Audit-Related Fees:** $40,000 in 2024. - **Total Fees:** $1,547,567 in 2024. **Exhibits:** - The amendment includes various exhibits, such as merger agreements, employment agreements, and equity incentive plans. **Future Outlook:** - The company aims to continue its growth and expansion in the healthcare sector, focusing on emergency departments and micro-hospitals. **Risk Factors:** - The company faces risks related to regulatory compliance, financial performance, and market competition. **Financial Condition:** - The company's financial condition is stable, with a focus on managing operational expenses and ensuring liquidity. **Market Position:** - Nutex Health Inc. is positioned as a leading provider of emergency healthcare services, with a growing network of facilities. **Changes Made in Amendment:** - The amendment includes the required information for Items 10 through 14 of Part III, which were previously omitted. No other changes were made to the Original Filing.